… of thyroid cancer is papillary thyroid carcinoma (PTC), which accounts for close to 85% of
all thyroid cancer.… , such as thyroidectomy, radioiodine, or thyroid-stimulating hormone (TSH) …

… Background: The management of aggressive and progressive metastatic papillary
thyroid cancer (PTC) is very difficult. An inverse relationship between radioiodine and F-18 …

… papillary thyroid cancer (PTC) risk among 3,175,216 ≥ 1-year adult survivors of non-thyroid
malignancies from US population-based cancer … detection of indolent thyroid tumors and …

… papillary thyroid cancer (PTC) to date. Based on genetic alterations reported by the “The
Cancer … alterations that may be targetable by drugs approved by the FDA for other solid cancers. …

… In the present work, we retrospectively investigated a case study comprising 1148 patients
affected by papillary thyroid cancer (PTC) to evaluate: (i) the effect of the new TNM-8 staging …

… in opposite directions in papillary thyroid cancer patients. In our … in papillary thyroid cancer
patients, however, PE-NMe (18:1/18:1) was in opposite directions in papillary thyroid cancer …

… Whether chronic lymphocytic thyroiditis (CLT) influences the risk of development and the
progression of papillary thyroid cancer (PTC) remains uncertain. We investigated the effects of …

… In the present study, we treated two human papillary thyroid cancer cell lines (KTC-1 and
TPC-1) with single or combined administration of rapamycin and resveratrol, and examined the …

Context The significance of low mitotic activity in papillary thyroid cancer (PTC) is largely
undefined. Objective We aimed to determine the behavioral landscape of PTC with low mitotic …

… Thyroid carcinoma (TC), the most frequent type of endocrine … into papillary thyroid cancer
(PTC), follicular thyroid cancer, Medullary thyroid cancer, Poorly differentiated thyroid cancer …